Triptolide enhances anti-cancer activities of irinotecan in human colon cancer HT-29 cells in vitro and HT-29 cell xenograft tumor model in nude mice.

Saved in:
Bibliographic Details
Title: Triptolide enhances anti-cancer activities of irinotecan in human colon cancer HT-29 cells in vitro and HT-29 cell xenograft tumor model in nude mice.
Authors: Ma YS; I-Shou University, Kaohsiung, Taiwan.; E-Da Cancer Hospital, Kaohsiung, Taiwan., Chueh FS; Asia University, Taichung, Taiwan., Huang YP; China Medical University, Taichung, Taiwan., Peng SF; China Medical University, Taichung, Taiwan.; China Medical University Hospital, Taichung, Taiwan., Kuo CL; China Medical University, Taichung, Taiwan., Chen JC; Da-Yeh University, Changhua, Taiwan., Hsu FT; National Central University, Taoyuan, Taiwan., Lai KC; China Medical University, Taichung, Taiwan.; Chung Hwa University of Medical Technology, Tainan, Taiwan., Lin YJ; Chang Bing Show-Chwan Memorial Hospital, Changhua County, Taiwan.
Source: Integrative cancer therapies [Integr Cancer Ther] 2026 Jan-Dec; Vol. 25, pp. 15347354261448871. Date of Electronic Publication: 2026 May 25.
Publication Type: Journal Article
Journal Info: Publisher: Sage Publications Country of Publication: United States NLM ID: 101128834 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-695X (Electronic) Linking ISSN: 15347354 NLM ISO Abbreviation: Integr Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1552-695X
DOI:10.1177/15347354261448871